Hong Kong Stock Announcement Highlights | Sanhua Intelligent Controls Issues Profit Alert with Expected Annual Net Profit Growth of 25%-50%

Stock News

2025/12/22

**Key Developments**: - SIMCERE PHARMA (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate). - CloudMinds (09678) launched the medical expert large-scale model "ShanHai·ZhiYi 5.0". - China Innovation Investment (00564) plans to establish Zhongchuang Zhiling (Zhengzhou) Industrial Investment Partnership for external investment activities. - BrainAct (06681) participated in a national key R&D project and was approved as a Beijing Key Laboratory for Cognitive Impairment Digital Therapeutics. - DeepTech (01384) entered into a strategic cooperation agreement with Moore Threads. - Shimao Services (00873) intends to form a partnership with Huludao Yongsheng.

**IPO Updates**: - Hansoh Biotech (03378) saw its Hong Kong public offering oversubscribed by 3,074.09x, with an issue price of HK$32 per share. - EasyHealth (02661) recorded 1,421.47x oversubscription for its Hong Kong public offering, priced at HK$22.68 per share. - NobiCart (02635) achieved 188.74x oversubscription for its Hong Kong public offering, priced at HK$80 per share.

**Operational Performance**: - SANHUA (02050) issued a profit alert, expecting annual attributable net profit to rise 25%-50% YoY. - CATHAY PAC AIR (00293) carried 2.53 million passengers in November, up 26% YoY. - Top Sports (06110) reported a high single-digit decline in total Q3 retail and wholesale sales.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1146574184"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146574184\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146574184?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-22 23:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146574184","market":"hk","top_or_hot":-1,"title":"Hong Kong Stock Announcement Highlights | Sanhua Intelligent Controls Issues Profit Alert with Expected Annual Net Profit Growth of 25%-50%","media":"Stock News","content":"<p>**Key Developments**:  \n- SIMCERE PHARMA (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate).  \n- CloudMinds (09678) launched the medical expert large-scale model \"ShanHai·ZhiYi 5.0\".  \n- China Innovation Investment (00564) plans to establish Zhongchuang Zhiling (Zhengzhou) Industrial Investment Partnership for external investment activities.  \n- BrainAct (06681) participated in a national key R&D project and was approved as a Beijing Key Laboratory for Cognitive Impairment Digital Therapeutics.  \n- DeepTech (01384) entered into a strategic cooperation agreement with Moore Threads.  \n- Shimao Services (00873) intends to form a partnership with Huludao Yongsheng.</p>\n<p>**IPO Updates**:  \n- Hansoh Biotech (03378) saw its Hong Kong public offering oversubscribed by 3,074.09x, with an issue price of HK$32 per share.  \n- EasyHealth (02661) recorded 1,421.47x oversubscription for its Hong Kong public offering, priced at HK$22.68 per share.  \n- NobiCart (02635) achieved 188.74x oversubscription for its Hong Kong public offering, priced at HK$80 per share.</p>\n<p>**Operational Performance**:  \n- SANHUA (02050) issued a profit alert, expecting annual attributable net profit to rise 25%-50% YoY.  \n- CATHAY PAC AIR (00293) carried 2.53 million passengers in November, up 26% YoY.  \n- Top Sports (06110) reported a high single-digit decline in total Q3 retail and wholesale sales.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Announcement Highlights | Sanhua Intelligent Controls Issues Profit Alert with Expected Annual Net Profit Growth of 25%-50%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Announcement Highlights | Sanhua Intelligent Controls Issues Profit Alert with Expected Annual Net Profit Growth of 25%-50%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-12-22 23:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>**Key Developments**:  \n- SIMCERE PHARMA (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate).  \n- CloudMinds (09678) launched the medical expert large-scale model \"ShanHai·ZhiYi 5.0\".  \n- China Innovation Investment (00564) plans to establish Zhongchuang Zhiling (Zhengzhou) Industrial Investment Partnership for external investment activities.  \n- BrainAct (06681) participated in a national key R&D project and was approved as a Beijing Key Laboratory for Cognitive Impairment Digital Therapeutics.  \n- DeepTech (01384) entered into a strategic cooperation agreement with Moore Threads.  \n- Shimao Services (00873) intends to form a partnership with Huludao Yongsheng.</p>\n<p>**IPO Updates**:  \n- Hansoh Biotech (03378) saw its Hong Kong public offering oversubscribed by 3,074.09x, with an issue price of HK$32 per share.  \n- EasyHealth (02661) recorded 1,421.47x oversubscription for its Hong Kong public offering, priced at HK$22.68 per share.  \n- NobiCart (02635) achieved 188.74x oversubscription for its Hong Kong public offering, priced at HK$80 per share.</p>\n<p>**Operational Performance**:  \n- SANHUA (02050) issued a profit alert, expecting annual attributable net profit to rise 25%-50% YoY.  \n- CATHAY PAC AIR (00293) carried 2.53 million passengers in November, up 26% YoY.  \n- Top Sports (06110) reported a high single-digit decline in total Q3 retail and wholesale sales.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1023057109.AUD","symbol_name":"BGF CHINA \"A2\" (AUDHDG) ACC","start_time":0,"source_url":"","article_id":"1146574184","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146574184","pubTimestamp":1766415912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"**Key Developments**:   - SIMCERE PHARMA (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate).   - CloudMinds (09678) launched the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","BK1183":"工业机械","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","BK0070":"员工持股","BK0259":"通用设备","BK1561":"航空股","BK1583":"高瓴概念","BK1123":"航空公司","LU1939255532.USD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (USD) ACC","LU2580892862.HKD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (HKD) ACC","LU2298064838.USD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (USD) INC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","00293":"国泰航空","02050":"三花智控","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","BK0188":"融资融券","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU2238339852.HKD":"NINETY ONE GSF GLOBAL ENVIRONMENT \"A\" (HKD) ACC","BK0187":"一线龙头","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0028":"国家队","BK0197":"中小创蓝筹","02096":"先声药业","BK1191":"制药","BK0076":"特斯拉","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0359201612.USD":"贝莱德中国基金A2","002050":"三花智控","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC"},"translate_title":"港股公告精华|三花智控发盈警预计全年净利增长25%-50%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02050":1,"02096":1,"002050":1,"00293":1},"content_text":"**Key Developments**:  \n- SIMCERE PHARMA (02096) subsidiary signed an exclusive licensing agreement with Ipsen for SIM0613 (LRRC15 antibody-drug conjugate).  \n- CloudMinds (09678) launched the medical expert large-scale model \"ShanHai·ZhiYi 5.0\".  \n- China Innovation Investment (00564) plans to establish Zhongchuang Zhiling (Zhengzhou) Industrial Investment Partnership for external investment activities.  \n- BrainAct (06681) participated in a national key R&D project and was approved as a Beijing Key Laboratory for Cognitive Impairment Digital Therapeutics.  \n- DeepTech (01384) entered into a strategic cooperation agreement with Moore Threads.  \n- Shimao Services (00873) intends to form a partnership with Huludao Yongsheng.\n**IPO Updates**:  \n- Hansoh Biotech (03378) saw its Hong Kong public offering oversubscribed by 3,074.09x, with an issue price of HK$32 per share.  \n- EasyHealth (02661) recorded 1,421.47x oversubscription for its Hong Kong public offering, priced at HK$22.68 per share.  \n- NobiCart (02635) achieved 188.74x oversubscription for its Hong Kong public offering, priced at HK$80 per share.\n**Operational Performance**:  \n- SANHUA (02050) issued a profit alert, expecting annual attributable net profit to rise 25%-50% YoY.  \n- CATHAY PAC AIR (00293) carried 2.53 million passengers in November, up 26% YoY.  \n- Top Sports (06110) reported a high single-digit decline in total Q3 retail and wholesale sales.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}